H. Lundbeck obtient le feu vert de l'UE pour l'utilisation de médicaments contre la schizophrénie chez les adolescents
H. Lundbeck a déclaré jeudi que l'Agence européenne des médicaments a autorisé l'utilisation élargie de son médicament contre ...
Le Rxulti de Lundbeck peut désormais être utilisé pour traiter la schizophrénie chez les adolescents dans l'UE.
Le médicament Rxulti de la société pharmaceutique danoise Lundbeck a été autorisé dans l'UE pour le traitement de la ...
Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
Seeking Alpha2d
HRMY Harmony Biosciences Holdings, Inc.
and EPX-200 (liquid formulation of lorcaserin), a selective 5HT-2C agonist to treat developmental and epileptic encephalopathies (DEE). The company was formerly known as Harmony Biosciences II ...
BMJ5d
Progressive myoclonic epilepsy as an adult-onset manifestation of Leigh syndrome due to m.14487T>C
Depending on the mutation load, it caused severe encephalopathies ranging from infantile LS to adult-onset PME with dystonia. This is the first report of PME as an important neurological manifestation ...
Yahoo Finance3d
Sage Therapeutics, Inc. (SAGE)
After hours: March 11 at 4:26:13 PM EDT Loading Chart for SAGE ...
BMJ2d
Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
The concept of antibody mediated CNS disorders is relatively recent. The classical CNS paraneoplastic neurological syndromes are thought to be T cell mediated, and the onconeural antibodies merely ...